|
To receive daily emails from Breaking Christian News to your inbox CLICK HERE
Exciting Discovery Offers Hope for Deadly Viral Pneumonia
(Charlottesville, VA)—Two drugs used to treat asthma and allergies may offer a way to prevent a form of pneumonia that can kill up to 40 percent of people who contract it, researchers at the University of Virginia School of Medicine have found. (Photo: Researchers Amber Cardani, PhD, and Thomas J. Braciale, MD, PhD/via UV Health) Influenza pneumonia results when a flu infection spreads to alveolar air sacs deep within the lungs. Normally, a flu infection does not progress that far into the lower respiratory tract, but when it does, the results can be deadly. "If infection is severe enough, and the immune response is potent enough, you get injury to these cells and are no longer able to get sufficient oxygen exchange," explained UVA researcher Thomas J. Braciale, MD, PhD. "As a result of the infection of the cells, you can develop lethal pneumonia and die." But early administration of the two asthma drugs, Accolate and Singulair, could prevent the infection of the alveolar cells deep in the lower respiratory tract, Braciale's research suggests. "The excitement of this is the possibility of someone coming to see the physician with influenza that looks a little more severe than usual and treating them with the drugs Singulair or Accolate and preventing them from getting severe pneumonia," he said. "The fatality rate from influenza pneumonia can be pretty high, even with all modern techniques to support these patients. Up to 40 percent. So it's a very serious problem when it occurs." Ounce of Prevention "When we look at pandemic strains of influenza that have high mortality rates, one of the best adaptations of those pandemic viruses is their ability to infect these alveolar epithelial cells," explained researcher Amber Cardani, PhD. "It's one of the hallmarks for certain strains that cause the lethality in these pandemics." Once influenza spreads deep into the lungs, the body's own immune response can prove harmful, resulting in severe damage to the alveolar air sacs. "It's an important observation the field is coming to," Cardani said. "We really need to limit the infection of these lower respiratory airways." Stopping the Flu Virus For their next steps, the researchers are consulting with colleagues to determine if patients being treated with Accolate and Singulair are less likely to develop influenza pneumonia during flu outbreaks. "This was a totally unexpected observation," Braciale said. "When I told multiple colleagues who are infectious disease or pulmonary physicians, they were absolutely flabbergasted."
To receive daily emails from Breaking Christian News to your inbox CLICK HERE
Other Recent Articles from Breaking Christian News 'Incredible' Archaeological Discovery Reveals Jewish Connection to Jerusalem's Ancient History DOJ to Investigate MLB's Threat to Discipline Players for Bible Verses on 'Pride' Hats Former Olympian among Several Sick Leftists Arrested for Vandalizing DC Reflecting Pool Another One! Colombia Does the RIGHT Thing. Now on to Brazil PM Keir Starmer Announces Resignation; How the British Labour Party Resembles American Democrats America of 1976 Would Not Recognize Herself in Our 250th Year Baseball Players Refuse to Wear Pride Uniforms, Forced to Forfeit Canada: Carney Liberals Move to 'Force' Radical Internet Surveillance Bill through House Belfast Is Burning, and the Media Won't Say Why Israel, Hezbollah Agree to New Ceasefire after Conflict Delayed US-Iran Talks Report: Biden-Era FDA Spun Autopsy Results to Downplay COVID Vaccine Deaths in Kids, Letter Shows From Pulisic's 'Bible Time' to Team Prayer on the Field, US Gives 'Glory to God' at World Cup Good News: Gasoline Drops Below $4 A Gallon Pennsylvania Governor Shapiro Abandoning 30,000 Children as Democrats Push to Strip School Choice Canada's Parliament Officially Passes 'Bible Ban' Bill C-9 Occupied Britain: Muslim Rape Gang Report Warns against Dangers of Mass Immigration (Part 1) Search the Articles Archives |
All articles on this site and emails from BCN are copyrighted property of Breaking Christian News. Permission is given to link to, or share a BCN story if proper attribution is given to both the original writer and summarizer of the story. Breaking Christian News 2005-2019. All Rights Reserved.
Breaking Christian News is a division of Elijah List Publications, Inc. All Rights Reserved
Disclaimer: Articles and links, as well as the source articles linked to; do not necessarily reflect the opinion of Breaking Christian News.
| Home | Store | Subscribe | Facebook | Article Archive |